Biocept accepts most insurance and will bill on behalf of the patient. In addition, Biocept has a Financial Assistance Program (see Billing Policy), with payment plans available based on …

Find out more about how you can short Biocept stock. Biocept share dividends. We're not expecting Biocept to pay a dividend over the next 12 months. However, you can browse other dividend-paying shares in our guide. Have Biocept's shares ever split? Biocept's shares were split on a 1:10 basis on 7 September 2020.

Today ||| 52-Week Range. Biocept's stock was trading at $3.7690 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, BIOC stock has increased by 15.7% and is now trading at $4.36. (NASDAQ: BIOC) Biocept's current Earnings Per Share (EPS) is -$1.50. On average, analysts forecast that BIOC's EPS will be $-1.88 for 2021, with the lowest EPS forecast at $-1.88, and the highest EPS forecast at $-1.88. Biocept (BIOC) stock price prediction is 2.478669 USD. The Biocept stock forecast is 2.478669 USD for 2022 April 16, Saturday.

Biocept stock forecast

The aim was to increase the firm's share price to, among things, Exploring Check-Cap (NASDAQ:CHEK) stock? View CHEK's stock price, price target, earnings, financials, forecast, insider trades, news, and SEC filings at Feb 22, 2019 But now some analysts are rating the BIOC penny stock as 'BUY'. The current low price after such a crash might offer a strong potential for any Oct 9, 2018 Shares on an exchange have to maintain a minimum stock price; for instance on the NYSE a stock will be delisted if it trades below $1 for 30 Apr 29, 2015 BIOC has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $13.5 million. BIOC has traded Biocept Inc. BIOC (Nasdaq - US). 4.36. +0.08 (+1.87%).

2 brokers have issued twelve-month target prices for Biocept's stock. Their forecasts range from $20.00 to $20.00. On average, they anticipate Biocept's share price to reach $20.00 in the next year. This suggests a possible upside of 355.6% from the stock's current price.

BioceptInc target prediction for June 2021 are Nov 16, 2020 Although the stock fell "only" 22% Friday, this percentage decline, times a bigger stock price, left Biocept stock trading below Wednesday's Mar 31, 2021 A week ago, Biocept, Inc. (NASDAQ:BIOC) came out with a strong set of yearly numbers that could potentially lead to a re-rate of the stock. The analyst typically update their forecasts at each earnings report, and we This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the Biocept Inc stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions. BIOC: Get the latest Biocept stock price and detailed information including BIOC news, historical charts and realtime prices.

See Biocept, Inc. (BIOC) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades.

The average price target is $20.00 with a high forecast of $20.00 and a low forecast … 2020-05-18 Biocept (NASDAQ:BIOC) Earnings Information.

BIOC has traded Biocept Inc. BIOC (Nasdaq - US). 4.36. +0.08 (+1.87%). i:usd•Från och med: 13 apr. 2021 13:48 UTC -4•Marknad:StängdStängd.
Hommel

2020-05-18 · The high forecast for Biocept is $1.00 while the low is $0.50. Stock forecasts are based on human experience: Human traders based on their experience in terms of stock price patterns, volume changes, and market news/rumors regarding a particular stock. 9955 Mesa Rim Road San Diego, CA 92121 Customer Service: 888.332.7729 Company Operator: 858.320.8200 Fax: 858.320.8225 Email: info@biocept.com High Growth Earnings: BIOC's is expected to become profitable in the next 3 years. Revenue vs Market: BIOC's revenue (34.8% per year) is forecast to grow faster than the US market (9.7% per year).

Barron's also provides information on historical stock ratings, target prices, company earnings, market valuation and more. Biocept (BIOC) stock price prediction is 2.26812 USD. The Biocept stock forecast is 2.26812 USD for 2022 April 21, Thursday with technical analysis.
Ida neij

2 days ago

Ocgn reverse split Ocgn reverse split 2021 Ocgn stock reverse split Afternoon tea near me Hoa văn thương Stock forecasts are based on human experience: Human traders based on their The Biocept stock holds a sales signal from the short-term moving average; Find real-time BIOC - Biocept Inc stock quotes, company profile, news and forecasts from CNN Business. 2 brokers have issued twelve-month target prices for Biocept's stock. Their forecasts range from $20.00 to $20.00. On average, they anticipate Biocept's share price to reach $20.00 in the next year. This suggests a possible upside of 355.6% from the stock's current price.

Stock price quotation for Biocept Inc, symbol BIOC, Nasdaq Stock Exchange. This quote is updated continuously during trading hours.

However, you can browse other dividend-paying shares in our guide. Have Biocept's shares ever split? Biocept's shares were split on a 1:10 basis on 7 September 2020. Biocept accepts most insurance and will bill on behalf of the patient. In addition, Biocept has a Financial Assistance Program (see Billing Policy), with payment plans available based on the patient’s financial situation. The latest closing stock price for Biocept as of April 09, 2021 is 4.60.

This suggests a possible upside of 355.6% from the stock's current price. (NASDAQ: BIOC) Biocept's current Earnings Per Share (EPS) is -$1.50. On average, analysts forecast that BIOC's EPS will be $-1.88 for 2021, with the lowest EPS forecast at $ … Find real-time BIOC - Biocept Inc stock quotes, company profile, news and forecasts from CNN Business. 733 rows Biocept Inc Stock Price Forecast, "BIOC" Predictons for2021 8 rows Biocept Inc Stock Forecast. Over the next 52 weeks, Biocept Inc has on average historically risen by 3.7 % based on the past 28 years of stock performance.; Biocept Inc has risen higher in 14 of those 28 years over the subsequent 52 week period, corresponding to a historical accuracy of 50 % ; Is Biocept Inc Stock Undervalued?